Alison Shaw

SAHPRA: Guidance on use of J&J COVID vaccine in pregnant and lactating mothers

Pregnant women are at higher risk of severe COVID-19 compared with women of childbearing age who are not pregnant, and COVID-19 has been associated with an increased risk of preterm birth. This document offers some preliminary recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine in pregnant or lactating women in the context of the Sisonke trial and in the future national rollout of the Janssen COVID-19 vaccine. These recommendations consider the safety of the vaccine including the recent reports of Vaccine induced Thrombotic Thrombocytopaenia (VITT).

Memorandum of Agreement with Respect to Coding Related Activities for Obstetricians and Gynaecologists

Click  HERE  to access the SASOG GMG Memorandum of Agreement with Respect to Coding Related Activities for Obstetricians…

Newly Elected SASOG Council 2021 – 2023

Welcome to the new SASOG Council members: PRESIDENT: Dr Haynes Van Der Merwe HON SECRETARY: Dr Malikah…

Presidents Report 2021 – End of term

Prof Greta Dreyer’s term office as President of SASOG has come to an end. Please find her…

FIGO CPD Credits

]

The science surrounding cerebral palsy (CP) indicates that it is a complex medical condition with multiple contributing variables and factors, and causal pathways are often extremely difficult to delineate.

High-value claims against obstetricians in litigation in both the public and private sectors are mostly related to…

Letter Regarding the HPCSA Annual Fee Increase

HPCSA Fee increase 2021 Objection Final – Flow

Tribute to Dr Chris Archer

It is with a deep sense of loss and profound sorrow that we learnt of the passing…

SASOG: Medico Legal Committee

Communication from the SASOG Medico-Legal Committee The Medico Legal Committee of SASOG has been, during the term…

Stock Update: Hormone patches Feb 2021

  Click HERE for full details.